Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Drug Development

Sanofi’s Zerhouni stepping down as research chief

by Lisa M. Jarvis
April 29, 2018 | A version of this story appeared in Volume 96, Issue 18

 

Headshot of retiring Sanofi R&D chief Elias Zerhouni.
Credit: Sanofi
Zerhouni
Headshot of incoming Sanofi R&D chief John Reed.
Credit: Roche
Reed

Sanofi’s head of R&D, Elias Zerhouni, will retire this summer. Zerhouni joined the big pharma firm in 2009, not long after stepping down as director of the U.S. National Institutes of Health. During his tenure, Sanofi put its R&D operations through an overhaul that included the sale or closure of multiple research sites. Zerhouni will be succeeded by John C. Reed, who currently leads research and early development at Roche.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.